Log in

NASDAQ:MGCDMGC Diagnostics Stock Price, Forecast & News

Notice: This company has been marked as potentially delisted and may not be actively trading.
0.00 (0.00 %)
(As of 01/8/2018)
Today's Range
Now: $11.03
50-Day Range N/A
52-Week Range
Now: $11.03
Average Volume15,965 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
MGC Diagnostics Corporation is a medical technology company, which offers cardiorespiratory health solutions. The Company designs, markets and sells non-invasive cardiorespiratory diagnostic products. It sells its products internationally through distributors and in the United States through a direct sales force targeting specialists located in hospitals, university-based medical centers, medical clinics, physician offices, pharmaceutical companies, medical device manufacturers and clinical research organizations (CROs). Its cardiorespiratory diagnostic products measure flow and respiratory pressures and, in most cases analyze the inhaled and exhaled gases, such as oxygen and carbon dioxide. Its products include pulmonary function (PFT) and gas exchange (GX) testing products. The Company's pulmonary function products are divided into four product categories: Spirometry, Complete Pulmonary Function, Body Plethysmography and Specialty Products.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.9Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.58 out of 5 stars

Industry, Sector and Symbol

Industry N/A
Current SymbolNASDAQ:MGCD
Previous SymbolNASDAQ:ANGN



Sales & Book Value

Annual SalesN/A



Next Earnings DateN/A
OptionableNot Optionable

Receive MGCD News and Ratings via Email

Sign-up to receive the latest news and ratings for MGCD and its competitors with MarketBeat's FREE daily newsletter.

MGC Diagnostics (NASDAQ:MGCD) Frequently Asked Questions

How were MGC Diagnostics' earnings last quarter?

MGC Diagnostics Corp (NASDAQ:MGCD) posted its earnings results on Wednesday, September, 7th. The medical equipment provider reported $0.06 earnings per share for the quarter. The medical equipment provider earned $9.90 million during the quarter, compared to analyst estimates of $9.20 million. View MGC Diagnostics' earnings history.

Has MGC Diagnostics been receiving favorable news coverage?

News stories about MGCD stock have been trending very negative on Sunday, according to InfoTrie. The research group scores the sentiment of media coverage by monitoring more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of negative five to five, with scores closest to five being the most favorable. MGC Diagnostics earned a media sentiment score of -3.8 on InfoTrie's scale. They also assigned press coverage about the medical equipment provider a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an impact on the company's share price in the next several days. View the latest news about MGC Diagnostics.

What other stocks do shareholders of MGC Diagnostics own?

Who are MGC Diagnostics' key executives?

MGC Diagnostics' management team includes the following people:
  • Greg Greenberg, Chairman of the Board
  • Matthew S. Margolies, President (Age 50)
  • Todd M. Austin, Chief Executive Officer (Age 54)
  • Larry Robert Degen, Interim Chief Financial Officer, Chief Accounting Officer, Secretary (Age 62)
  • Hendrik Struik, Independent Director (Age 49)

What is MGC Diagnostics' stock symbol?

MGC Diagnostics trades on the NASDAQ under the ticker symbol "MGCD."

What is MGC Diagnostics' stock price today?

One share of MGCD stock can currently be purchased for approximately $11.03.

What is MGC Diagnostics' official website?

The official website for MGC Diagnostics is mgcdiagnostics.com.

How can I contact MGC Diagnostics?

MGC Diagnostics' mailing address is 350 Oak Grove Pkwy, SAINT PAUL, MN 55127-8507, United States. The medical equipment provider can be reached via phone at +1-651-4844874 or via email at [email protected]

This page was last updated on 7/12/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.